Funding for a program that covers 9 million kids expired. Republicans want something in return for extending it, Vox reports. » Read More
By: Dan Mangan
The Trump administration takes two new steps in its ongoing fight against abortion. » Read More
By: Angelica LaVito
President Donald Trump has repeatedly condemned high drug prices, but hasn't done much to lower them one year in office. » Read More
Cozying up to health investors is now a full-time job.
Jim Cramer said an overload of buyers in the stock market is resulting in dramatically rising stock prices.
Thanks to earlier detection, improved screening and innovative treatments, certain types of cancer are becoming more manageable than before.
A consortium representing more than 450 hospitals plan to create their own generic drug company.
Ethan Perlstein didn't shy away from sharing everything with CNBC, including his personal salary, rejections and revenues.
Buying Juno could help Celgene diversify its portfolio as its top-selling drug approaches patent expiration.
Abortion rights and LGBT advocates are pushing back against a bid to shield health workers who refuse to perform services on moral grounds.
Several major hospital systems plan to form a drug company that will provide generic drugs in short supply to the hospitals, the New York Times reports.
Trump said he gets more exercise than people think, but he was open to changing his diet, starting with smaller portion meal sizes.
Chinese bidders are circling a diabetes care business owned by the world’s largest healthcare company, Johnson & Johnson.
The move comes as the Health and Human Services Department has opposed efforts by several undocumented immigrant teens to obtain abortions.
Caring for a sick or elderly relative is already stressful. Here's what it can do to your wallet.
President Trump created a whistleblower-protection office, which has stepped in to help more than 70 VA employees, USA Today reported.
Medical breakthroughs in 2018 range from new devices for sleep apnea to gene therapy for blindness, according to the Cleveland Clinic.
Chinese bidders are circling Johnson & Johnson's diabetes care business in a deal that could fetch up to $4 billion.
The product, DisposeRX, mixes with drugs and warm water to form a solid that can be safely thrown out in the trash.
Get the best of CNBC in your inbox